NCT05449301

Brief Summary

According to the definition proposed by the World Health Organization, "stroke is rapidly developing clinical signs of focal (or global) disturbance of cerebral function, with symptoms lasting 24 hours or longer, or leading to death, with no apparent cause other than of vascular origin". Difficulty in walking is present in approximately 80% of stroke survivors. 25% of stroke survivors even after getting rehabilitation have residual gait impairments requiring full assistance after hospital discharge resulting in difficulties in performing basic activities of daily life. Approaches to gait rehabilitation are different based on different models of motor physiology and disease recovery, but most of the approaches are targeting motor impairments during straight walking only as opposed to adaptive walking ability . In order to decrease health care burden effective rehabilitation and prevention is necessary. Multidisciplinary care dedicated for stroke leads to higher independence rates. Conventional gait training regimes including linear parallel bar based gait training and treadmill based gait training protocols do not usually target the angular or rotational component of locomotion. Current study will focus on Unilateral Step Training using a traditional treadmill. This would provide a targeted gait training tool to reduce the risk of fall, improve gait and turning ability and functional activity eventually resulting in greater community participation and involvement in occupational activities. Such an approach could be effective in providing an early targeted and intense training environment similar to task-specific training in contrast to conventional method.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 4, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 8, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

December 31, 2025

Status Verified

December 1, 2025

Enrollment Period

1.5 years

First QC Date

July 4, 2022

Last Update Submit

December 23, 2025

Conditions

Keywords

BalanceGaitMobility

Outcome Measures

Primary Outcomes (6)

  • 3D clinical gait assessment (Motion Metrix)

    MotionMetrix's 3D Clinical Gait system provides a standard set of gait parameters in which most pathological conditions are reflected. Clinicians can therefore use it to efficiently screen for a variety of conditions and to follow up on corrective measures.

    12 weeks

  • Wisconsin gait

    Wisconsin Gait Scale (WGS) is an observational tool for the evaluation of gait quality in individuals after stroke with hemiplegia. It is divided into four subscales, which assess a total of fourteen spatiotemporal and kinematic parameters of gait observed during the consecutive gait phases.

    12 weeks

  • Figure of eight walk test

    The Figure of 8 Walk Test (F8WT) measures the everyday walking ability with mobility disability. The F8WT tests a participant's gait in both straight and curved paths (r=0.81). The F8WT uses a path where the participant is asked to walk a figure of eight shape around two cones. Scores are recorded in three areas: 1) speed (time for completion), 2) amplitude (number of steps taken), and 3) accuracy or "smoothness".

    12 weeks

  • Biodex balance system

    it is used to assess objectively balance and also improving balance, increasing agility, developing muscle tone, treating a wide variety of pathologies. it is easy-to-follow "touchscreen" operation, the Balance System is simple to operate, leading the user step-by-step in testing protocols and training modes in both static and dynamic formats

    12 weeks

  • Timed Up and Go Test

    The Timed Up and Go Test (TUG) is an objective clinical measure for assessing functional mobility and balance, and thus the risk of falling. The TUG measures the time taken for an individual to rise from a chair, walk 3 meters, turn, walk back and sit down

    12 weeks

  • Berg Balance Scale

    The Berg Balance Scale assesses the balance of patients with different neurological disorders. Performance is assessed on different tasks and each task is graded with a 5- point ordinal scale ranging from 0 to 4, with higher scores awarded because of speed, stability, or help required for completion of the task. It summed the task scores to give a total BBS score out of a possible 56 points with higher scores representing better balance.

    12 weeks

Secondary Outcomes (2)

  • Fugl-Meyer Assessment (FMA)

    12 weeks

  • Stroke specific quality of life

    12 weeks

Study Arms (3)

Control Group

ACTIVE COMPARATOR

The control group will receive Conventional Treadmill training for Gait \& balance impairment.

Other: Treadmill Training

Rhythmic Auditory Stimulation Training Group

EXPERIMENTAL

Participants will be trained conventionally (bipedal) on regular treadmill along with Rhythmic Auditory Stimulation.

Other: Rhythmic Auditory StimulationOther: Treadmill Training

Unilateral Step Training Group

EXPERIMENTAL

The participants will be trained with regular treadmill for unilateral step for both paretic and non-paretic lower extremity

Other: Unilateral Step Training

Interventions

participants will be trained conventionally (bipedal) on regular treadmill. one session per day, 3 session per week for consecutively 12 weeks.

Control GroupRhythmic Auditory Stimulation Training Group

The participants will receive RAS on regular treadmill for balance and gait improvement. one session per day, 3 session per week for consecutively 12 weeks.

Rhythmic Auditory Stimulation Training Group

Patients will be trained on regular treadmill for both paretic and non paretic lower extremity. Single session per day, 3 session per week for consecutively 12 weeks.

Unilateral Step Training Group

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Both Genders.
  • Age: 40-60 years
  • Ischemic stroke
  • Patients having stroke involving Middle Cerebral Artery
  • Patients in sub-acute (3 months) and chronic phase (6 months) of stroke
  • Mini-Mental State Exam score \> 24
  • Functional Ambulatory Capacity: 3-5

You may not qualify if:

  • Patients with unstable medical conditions (e.g., DVT, uncontrolled hypertension, uncontrolled diabetes and musculoskeletal injuries)
  • History of other diseases known to interfere with participation in the study (e.g., heart failure, epilepsy)
  • Participants with cognitive impairment.
  • Score of muscle tone on Modified Ashworth Scale: 3-4

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foundation University College of Physical Therapy

Islamabad, 44000, Pakistan

Location

Related Publications (1)

  • Khalid S, Malik AN, Siddiqi FA. Effects of unilateral step training along with rhythmic auditory stimulation on balance and postural stability in stroke patients. Sci Rep. 2026 Mar 9. doi: 10.1038/s41598-026-41790-y. Online ahead of print.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Arshad N Malik, PhD

    Riphah International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2022

First Posted

July 8, 2022

Study Start

January 1, 2023

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

December 31, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations